{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:06:21Z","timestamp":1777421181139,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.110244","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T07:28:45Z","timestamp":1599204525000},"page":"110244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 disease"],"prefix":"10.1016","volume":"143","author":[{"given":"Yaron","family":"Niv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110244_b0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jiph.2020.03.019","article-title":"Coronavirus disease 2019 (COVID-19): A literature review","volume":"13","author":"Harapana","year":"2020","journal-title":"J Infect Pub Health"},{"key":"10.1016\/j.mehy.2020.110244_b0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110244_b0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.mehy.2020.110244_b0020","unstructured":"Chain a. Spike glycoprotein \u2013 protein \u2013 NCBI. https:\/\/www.ncbi.nlm.nih.gov\/protein\/6YOR_A."},{"key":"10.1016\/j.mehy.2020.110244_b0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"The lancet"},{"key":"10.1016\/j.mehy.2020.110244_b0030","doi-asserted-by":"crossref","unstructured":"Wang C, Wang S, Li D, Wei DQ, Zhao J, Wang J. Human intestinal defensin 5 inhibits SARS-CoV-19 invasion by cloaking ACE2. Gastroenterology \u2013 in press. https:\/\/doi.org\/10.1101\/2020.03.29.013490.","DOI":"10.1101\/2020.03.29.013490"},{"key":"10.1016\/j.mehy.2020.110244_b0035","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.mehy.2020.110244_b0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1023\/A:1007568511399","article-title":"The surface composition of spray-dried trehalose\/bovine serum albumin\/surfactant particle","volume":"17","author":"Adler","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.mehy.2020.110244_b0045","doi-asserted-by":"crossref","unstructured":"Perencevich EN, Diekema DJ, Edmond MB. Moving personal protective equipment into the community. Face shields and containment of Covid-19. JAMA 2020;online April 29.","DOI":"10.1001\/jama.2020.7477"},{"key":"10.1016\/j.mehy.2020.110244_b0050","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.powtec.2020.01.001","article-title":"Particle morphology and powder properties during spray drying of maltodextrin and whey protein mixtures","volume":"363","author":"Both","year":"2020","journal-title":"Powder Technol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720326761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720326761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:33:17Z","timestamp":1759692797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720326761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":10,"alternative-id":["S0306987720326761"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110244","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 disease","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110244"}}